Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVIPLEX: Plasma Exchange for Severe COVID-19
NCT04623255Phase 2Completed
- Sponsor
- University College London
- Start
- Oct 2020
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 2 trial of fresh-frozen plasma in coronavirus disease 2019 (COVID-19), sponsored by University College London. Started Oct 2020; status: completed.
02
Drugs
fresh-frozen plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04623255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04623255.